Moderna Triumphs: European Patent Office Upholds Key COVID Shot Patent in Pfizer-BioNTech Dispute
Moderna Triumphs: European Patent Office Upholds Key COVID Shot Patent in Pfizer-BioNTech Dispute
Moderna secured a victory in a European Patent Office decision, upholding one of its key patents in the COVID-19 vaccine dispute with Pfizer-BioNTech.
Moderna secured a victory in a European Patent Office decision, upholding one of its key patents in the COVID-19 vaccine dispute with Pfizer-BioNTech.
Moderna sued Pfizer-BioNTech in 2022, accusing them of copying its mRNA technology used in their COVID shot, Comirnaty.
Moderna sued Pfizer-BioNTech in 2022, accusing them of copying its mRNA technology used in their COVID shot, Comirnaty.
The European Patent Office upheld Moderna's patent, giving the business a victory in its continuing lawsuit against Pfizer.
The European Patent Office upheld Moderna's patent, giving the business a victory in its continuing lawsuit against Pfizer.
A Massachusetts federal court recently put a related patent lawsuit on hold pending a U.S. Patent Office review of two of the three Moderna patents involved.
A Massachusetts federal court recently put a related patent lawsuit on hold pending a U.S. Patent Office review of two of the three Moderna patents involved.
Did You Know?China and the US lead in COVID-19 vaccine patents! China has 573 applications, the US has 356
Did You Know?China and the US lead in COVID-19 vaccine patents! China has 573 applications, the US has 356
For Patent Registration get in touch with Vakilsearch